Literature DB >> 33510130

Genetic and clinical analyses of psychosis spectrum symptoms in a large multiethnic youth cohort reveal significant link with ADHD.

Loes M Olde Loohuis1, Eva Mennigen2,3, Anil P S Ori2, Diana Perkins4, Elise Robinson5,6,7, Jean Addington8, Kristin S Cadenhead9, Barbara A Cornblatt10, Daniel H Mathalon11, Thomas H McGlashan12, Larry J Seidman13, Matcheri S Keshavan13, William S Stone13, Ming T Tsuang9, Elaine F Walker14, Scott W Woods12, Tyrone D Cannon15, Ruben C Gur16, Raquel E Gur16, Carrie E Bearden2,17, Roel A Ophoff18,19,20.   

Abstract

Psychotic symptoms are not only an important feature of severe neuropsychiatric disorders, but are also common in the general population, especially in youth. The genetic etiology of psychosis symptoms in youth remains poorly understood. To characterize genetic risk for psychosis spectrum symptoms (PS), we leverage a community-based multiethnic sample of children and adolescents aged 8-22 years, the Philadelphia Neurodevelopmental Cohort (n = 7225, 20% PS). Using an elastic net regression model, we aim to classify PS status using polygenic scores (PGS) based on a range of heritable psychiatric and brain-related traits in a multi-PGS model. We also perform univariate PGS associations and evaluate age-specific effects. The multi-PGS analyses do not improve prediction of PS status over univariate models, but reveal that the attention deficit hyperactivity disorder (ADHD) PGS is robustly and uniquely associated with PS (OR 1.12 (1.05, 1.18) P = 0.0003). This association is driven by subjects of European ancestry (OR = 1.23 (1.14, 1.34), P = 4.15 × 10-7) but is not observed in African American subjects (P = 0.65). We find a significant interaction of ADHD PGS with age (P = 0.01), with a stronger association in younger children. The association is independent of phenotypic overlap between ADHD and PS, not indirectly driven by substance use or childhood trauma, and appears to be specific to PS rather than reflecting general psychopathology in youth. In an independent sample, we replicate an increased ADHD PGS in 328 youth at clinical high risk for psychosis, compared to 216 unaffected controls (OR 1.06, CI(1.01, 1.11), P = 0.02). Our findings suggest that PS in youth may reflect a different genetic etiology than psychotic symptoms in adulthood, one more akin to ADHD, and shed light on how genetic risk can be investigated across early disease trajectories.

Entities:  

Mesh:

Year:  2021        PMID: 33510130      PMCID: PMC7844241          DOI: 10.1038/s41398-021-01203-2

Source DB:  PubMed          Journal:  Transl Psychiatry        ISSN: 2158-3188            Impact factor:   6.222


  55 in total

1.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

Review 2.  All for One and One for All: Mental Disorders in One Dimension.

Authors:  Avshalom Caspi; Terrie E Moffitt
Journal:  Am J Psychiatry       Date:  2018-04-06       Impact factor: 18.112

3.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies.

Authors:  Brendan K Bulik-Sullivan; Po-Ru Loh; Hilary K Finucane; Stephan Ripke; Jian Yang; Nick Patterson; Mark J Daly; Alkes L Price; Benjamin M Neale
Journal:  Nat Genet       Date:  2015-02-02       Impact factor: 38.330

4.  Human Demographic History Impacts Genetic Risk Prediction across Diverse Populations.

Authors:  Alicia R Martin; Christopher R Gignoux; Raymond K Walters; Genevieve L Wojcik; Benjamin M Neale; Simon Gravel; Mark J Daly; Carlos D Bustamante; Eimear E Kenny
Journal:  Am J Hum Genet       Date:  2017-03-30       Impact factor: 11.025

Review 5.  Clinical use of current polygenic risk scores may exacerbate health disparities.

Authors:  Alicia R Martin; Masahiro Kanai; Yoichiro Kamatani; Yukinori Okada; Benjamin M Neale; Mark J Daly
Journal:  Nat Genet       Date:  2019-03-29       Impact factor: 38.330

6.  At-risk studies and clinical antecedents of psychosis, bipolar disorder and depression: a scoping review in the context of clinical staging.

Authors:  Jessica A Hartmann; Barnaby Nelson; Aswin Ratheesh; Devi Treen; Patrick D McGorry
Journal:  Psychol Med       Date:  2018-06-04       Impact factor: 7.723

Review 7.  A systematic review of the prevalence of schizophrenia.

Authors:  Sukanta Saha; David Chant; Joy Welham; John McGrath
Journal:  PLoS Med       Date:  2005-05-31       Impact factor: 11.069

8.  Identification of 15 genetic loci associated with risk of major depression in individuals of European descent.

Authors:  Craig L Hyde; Michael W Nagle; Chao Tian; Xing Chen; Sara A Paciga; Jens R Wendland; Joyce Y Tung; David A Hinds; Roy H Perlis; Ashley R Winslow
Journal:  Nat Genet       Date:  2016-08-01       Impact factor: 38.330

9.  Multi-polygenic score approach to trait prediction.

Authors:  E Krapohl; H Patel; S Newhouse; C J Curtis; S von Stumm; P S Dale; D Zabaneh; G Breen; P F O'Reilly; R Plomin
Journal:  Mol Psychiatry       Date:  2017-08-08       Impact factor: 15.992

10.  Association of Genetic Liability to Psychotic Experiences With Neuropsychotic Disorders and Traits.

Authors:  Sophie E Legge; Hannah J Jones; Kimberley M Kendall; Antonio F Pardiñas; Georgina Menzies; Matthew Bracher-Smith; Valentina Escott-Price; Elliott Rees; Katrina A S Davis; Matthew Hotopf; Jeanne E Savage; Danielle Posthuma; Peter Holmans; George Kirov; Michael J Owen; Michael C O'Donovan; Stanley Zammit; James T R Walters
Journal:  JAMA Psychiatry       Date:  2019-12-01       Impact factor: 21.596

View more
  1 in total

1.  Copy Number Variant Risk Scores Associated With Cognition, Psychopathology, and Brain Structure in Youths in the Philadelphia Neurodevelopmental Cohort.

Authors:  Aaron Alexander-Bloch; Guillaume Huguet; Laura M Schultz; Nicholas Huffnagle; Sebastien Jacquemont; Jakob Seidlitz; Zohra Saci; Tyler M Moore; Richard A I Bethlehem; Josephine Mollon; Emma K Knowles; Armin Raznahan; Alison Merikangas; Barbara H Chaiyachati; Harshini Raman; J Eric Schmitt; Ran Barzilay; Monica E Calkins; Russel T Shinohara; Theodore D Satterthwaite; Ruben C Gur; David C Glahn; Laura Almasy; Raquel E Gur; Hakon Hakonarson; Joseph Glessner
Journal:  JAMA Psychiatry       Date:  2022-07-01       Impact factor: 25.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.